Aprea Therapeutics Inc (APRE)

3.972 +0.05 (+1.32%) USD  |  NASDAQ  |  Nov 04, 16:00
4.06 +0.09 (+2.22%) Pre-Market: 20:00
More

Aprea Therapeutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Assets (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

Aethlon Medical Inc Upgrade
Brainstorm Cell Therapeutics Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade

EV to Assets (Quarterly) Related Metrics

EV to Free Cash Flow Upgrade